Biosimilars Market By Product Types, Application, Regions and Key Manufacturers - Astra, Zeneca, Pfizer, Biocon, Novartis, Teva Pharma and STADA
Global Biosimilars Market - Industry Analysis, Share, Trend, Market Size and Forecast was estimated to be around US$ 6.45 billion in 2017 and is anticipated to grow with 55.0% of growth rate during the future period. This report segments the global Biosimilars Market by product type, application and geography. Biosimilars are the biologics pharmaceutical drugs which are similar to the reference biologic products. These drugs are an interchangeable biological product that contains synthetically developed protein molecules. When the patent of branded drug is expired, pharmaceutical companies are planning to develop off-patent biologics i.e. biosimilars that offer similar biological activity. The biosimilars market offers many growth opportunities and driving factors as compared to the restraining factors. It is stated by various research scientists that development of biosimilars will drastically reduce the price of pharmaceutical drugs.FREE | Request Sample Copy is Available at http://www.reportsweb.com/inquiry&RW00011327804/sample
In terms of product types, the market for recombinant glycosylated proteins continue to dominate during the forecast period, while the market for recombinant non-glycosylated proteins biosimilars will see a huge potential during the forecast period. On other side, oncology was the largest application segment in 2016, and expected to be the fastest growing application segment in the forecast period. The rise in the aging population, increasing cancer patients, and rise of hospital acquired infection patients globally are factors responsible for the growth of this application segment. The market size and forecast for each segment has been provided for the period 2014 to 2025, considering 2016 as the base year. The report also provides the compounded annual growth rate (% CAGR) for the forecast period 2017 to 2025 for every reported segment.
The report aims at estimating the market size and future growth potential of market across different segments, such as product types, application and regions.
The years considered for the study are:
Historical Year - 2014 & 2015
Base Year - 2016
Estimated Year - 2017
Projected Year - 2025
Companies reported in this report are: Amgen, Inc, AstraZeneca, Pfizer, Inc., BIOCON Limited, Novartis AG, STADA, Teva Pharmaceuticals Inc. and Others. For company profiles in the report, 2014 has been considered. Where information is unavailable for the base year, the prior year has been considered.
Inquire about this Report at http://www.reportsweb.com/inquiry&RW00011327804/buying
TARGET AUDIENCE
Hospitals
Manufacturers
Traders, Distributors, And Suppliers of Biosimilars
Government and Regional Agencies and Research Organizations
Consultants
Distributors
SCOPE OF THE REPORT
The research report categorizes the Biosimilars Market in each of the following submarkets to forecast the revenues and analyze the trends:
GLOBAL BIOSIMILARS MARKET, BY PRODUCT TYPES
Recombinant Glycosylated Proteins
Recombinant Non-Glycosylated Proteins
Recombinant Peptides
GLOBAL BIOSIMILARS MARKET, BY APPLICATION
Oncology
Blood Disorders
Infectious Diseases
Autoimmune Diseases
Others
GLOBAL BIOSIMILARS MARKET, BY REGION
North America
Europe
Asia Pacific
Rest of the World
Complete Report is Available at http://www.reportsweb.com/biosimilars-market-analysis-and-forecast-report-2018-2025
GLOBAL BIOSIMILARS MARKET, GEOGRAPHIC ANALYSIS
Further Breakdown of The North America Biosimilars Market
U.S.
Canada
Further Breakdown of The Europe Biosimilars Market
Germany
France
Rest of Europe
Further Breakdown of The APAC Biosimilars Market
India
China
Rest of APAC
Further Breakdown of The Rest of the World Biosimilars Market
Middle East and Africa
Latin America
Contact Us:
Phone: +1-646-491-9876
Email Id: sales@reportsweb.com
About ReportsWeb:
ReportsWeb is a one stop shop of market research reports and solutions to various companies across the globe. We help our clients in their decision support system by helping them choose most relevant and cost effective research reports and solutions from various publishers.
533, 5th Floor, Amanora Chambers,
Amanora Township, East Block,
Kharadi Road, Hadapsar, Pune-411028
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Biosimilars Market By Product Types, Application, Regions and Key Manufacturers - Astra, Zeneca, Pfizer, Biocon, Novartis, Teva Pharma and STADA here
News-ID: 944684 • Views: …
More Releases from ReportsWeb
North America: Smart Airport Market Overall Study Report 2020-2026| Amadeus IT G …
The "Global North America Smart Airport Market: 2020" Industry Report is a professional and in-depth study on the current state of the North America Smart Airport Market by PMR. The North America Smart Airport market is supposed to demonstrate a considerable growth during the forecast period of 2020 - 2026. The company profiles of all the key players and brands that are dominating the market have been given in this…
Marine Biotechnology Market Future Forecast 2018-2026 by Leading Companies such …
ReportsWeb.com has announced the addition of the “Marine Biotechnology-Global Market Outlook 2017-2026” The report classifies the global Marine Biotechnology Market in a precise manner to offer detailed insights about the aspects responsible for augmenting as well as restraining market growth.
According to Publisher, the Global Marine Biotechnology Market is accounted for $3.93 billion in 2017 and is expected to reach $8.74 billion by 2026 growing at a CAGR of 9.3% during…
Anti-Counterfeiting Packaging Market Growth Opportunities and Emerging Trends by …
ReportsWeb.com has announced the addition of the “Anti-Counterfeiting Packaging-Global Market Outlook 2017-2026” The report classifies the global Anti-Counterfeiting Packaging Market in a precise manner to offer detailed insights about the aspects responsible for augmenting as well as restraining market growth.
According to Publisher, the Global Anti-Counterfeiting Packaging Market is accounted for $112.16 billion in 2017 and is expected to reach $427.96 billion by 2026 growing at a CAGR of 16.0% during…
Solar Photovoltaic in Italy Market Outlook to 2030 | Company Profiles (Tozzi Hol …
Solar Photovoltaic (PV) in Italy, Market Outlook to 2030, Update 2018-Capacity, Generation, Investment Trends, Regulations and Company Profiles
Summary
"Solar Photovoltaic (PV) in Italy, Market Outlook to 2030, Update 2018-Capacity, Generation, Investment Trends, Regulations and Company Profiles", is the latest report from Publisher, the industry analysis specialists that offer comprehensive information and understanding of the Solar Photovoltaic (PV) market in Italy.
The report provides in depth analysis on global renewable power market and…
More Releases for Biosimilars
Global Biosimilars Market 2021-2028 | Price Advantage of Biosimilars Over Biolog …
The global Biosimilars market focuses on encompassing major statistical evidence for the Biosimilars industry as it offers our readers a value addition on guiding them in encountering the obstacles surrounding the market. A comprehensive addition of several factors such as global distribution, manufacturers, market size, and market factors that affect the global contributions are reported in the study. In addition, the Biosimilars study also shifts its attention with an in-depth…
Growth of the Biosimilars Market Is Mainly Driven by Increasing Number of Approv …
A biosimilar is a biologic medical product that is similar to another already approved biological medicine, in terms of quality, safety, and efficacy. Biosimilars are a class of therapeutic drugs that provide additional treatment options and help reduce healthcare costs. Thus, there is an increasing demand for biosimilar drugs due to increasing prevalence of autoimmune diseases, key factor driving the growth of the biosimilars market. According to the National Stem…
Global Oncology Biosimilars Market | Global Oncology Biosimilars Industry | Onco …
The oncology biosimilars market involves of sales of medicine and drug interrelated products for cancer treatment. Biosimilars are pharmaceuticals which are produced using cell lines and are fashionable to the manufacturer. The manufacturing of such cell line processes is a multipart and time-consuming procedure.
According to the report analysis, ‘Oncology Biosimilars Market Global Report 2020-30’ states that the worldwide oncology biosimilars market was worth USD 2990.34 million in 2019. It is…
Global Biosimilars Market | Global Biosimilars Industry | Global Biosimilars Mar …
The biosimilars market involves of sales of biosimilars and associated services that are cast-off to treat chronic sicknesses such as diabetes, arthritis, and cancer. The Biosimilars are pharmaceuticals that are produced using cell lines and offers no clinical difference as linked to biologics. The Biosimilars are made once the patent of biologics is deceased.
According to the report analysis, ‘Biosimilars Market Global Report 2020-30’ states that the worldwide biosimilars market was…
Global Oral Biologics and Biosimilars Market | Global Oral Biologics and Biosimi …
The oral biologics and biosimilar market contain of sales of oral biologics and biosimilar products and associated services utilized to treat chronic syndromes such as diabetes, arthritis, cancer. Biologics are drugs completed from living cells using exceedingly complex technology while biosimilars are generated to function similarly to biologics but are not matching to biologics. Biosimilars offer energetic properties as any licensed biologic drug. The oral biologics and biosimilar market encompass…
Insulin Biosimilars Market, by Biosimilar Type Rapid-acting Biosimilars, Long-ac …
Diabetes is a group of metabolic disease characterized by high blood sugar level due to inadequate secretion of insulin. Common symptoms of diabetes include increased hunger, tiredness, weight loss, and excessive thirst and urination. The prevalence of diabetes is increasing, in turn, boosting demand for insulin biosimilar. For instance, according the World Health Organization (WHO) report in 2014, globally around 422 million adults were living with diabetes and 1.5 million…